CytoDyn Inc (QB) (CYDY)
USOTC
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current CYDY market cap is 185.16M. The company's latest EPS is USD -0.0406 and P/E is -3.69.
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 266k | 0 | 0 |
| Operating Income | -74.65M | -104.6M | -71.91M | -40.58M | -18.06M |
| Net Income | -124.4M | -154.67M | -210.82M | -79.82M | -49.84M |
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 50.51M | 132.08M | 29.19M | 11.29M | 11.14M |
| Total Liabilities | 52.99M | 153.1M | 123.58M | 120.79M | 127.89M |
| Total Equity | -2.48M | -21.02M | -94.4M | -109.5M | -116.76M |
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -68.8M | -117.57M | -77.72M | -25.11M | -10.98M |
| Investing | -41k | -122k | N/A | N/A | N/A |
| Financing | 79.67M | 137.35M | 48.01M | 29.93M | 11.75M |
| Market Cap | 185.16M |
| Price to Earnings Ratio | -3.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 60 |
| Price to Book Ratio | -1.58 |
| Dividend Yield | - |
| Shares Outstanding | 1.23B |
| Average Volume (1 week) | 2.18M |
| Average Volume (1 Month) | 2.72M |
| 52 Week Change | -23.13% |
| 52 Week High | 0.315 |
| 52 Week Low | 0.1031 |
| Spread (Intraday) | 0 (0.2%) |
| Company Name | CytoDyn Inc (QB) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cytodyn.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
